banner biotek2

  • tpntb2016
  • pksbanyumulek2016
  • ibbanyumulek
  • demo
  • RRT delegations
  • ISIBIO 2016
  • lkj2015-a
  • openhouse1
  • ristekdikti2016
  • Pengembangan Techno Park Banyumulek: Penanaman Bibit Tanaman Buah oleh Pejabat LIPI di Lokasi Techno Park Banyumulek-NTB, 20 Mei 2016
  • Penandatanganan Perjanjian Kerja Sama Inovasi IPTEK TP Banyumulek 2016 antara Pusat Penelitian Bioteknologi-LIPI, Fakultas Pertanian Universitas Mataram, Pemerintah Kabupaten Lombok Utara dan PT Gerbang NTB Emas, 20 Mei 2016.
  • Pusat Penelitian Bioteknologi LIPI bekerjasama dengan Dinas Peternakan dan Kesehatan Hewan Provinsi Nusa Tenggara Barat mengadakan pelatihan recording sapi, 19-20 April 2016
  • Demo Praktik Perbanyakan Tanaman Secara Vegetatif Pada Pameran "Indonesia Climate Change Education Forum and Expo 2016 (ICCEFE)" ke-6 di Jakarta Convention Center (JCC), 14-17 April 2016
  • Kunjungan Delegasi Republik Rakyat Tiongkok Ke Puslit Bioteknologi LIPI Dalam Rangka "Halal Food Biotechnology", 2 April 2016
  • The Third International Symposium on Integrated Biorefinery (ISIBIO)- Wednesday, September 21st, 2016
  • Biotechnology for Better Life
  • kunjungan Duta Besar Indonesia Untuk Equador, Dra. Diennaryati Tjokrosuprihatono, M.Psi Ke Puslit Bioteknologi LIPI Pada Tanggal 23 Februari 2016.
  • Kunjungan Wapres Jusuf Kalla ke Booth Pameran LIPI Pada Pameran Rakernas Ristek Dikti, 1-2 Februari 2016.

annales

terbitan

Print

Heterologous Expression of recombinant Plantaricin WS34 in Escherichia coli

ws34Plantaricin W is a two peptide lantibiotic produced by lactobacillus plantarumS34 isolated from bekasam, a traditional fermented food of meat products from Waykanan, Lampung. Plantaricin W is a potential antimicrobial peptide. however, the expression of recombinant plantaricin W has not been reported. To express a recombinant plantaricin WS34, we constructed and expressed the gene encoding plantaricin W in pET-32a by using the T7 RNA polymerase promoter with approximately 33 kDa in size in escherichia coliBL21 (DE3)(pLysS).

Print

Isolation and Cloning of Partial her-2 Gene from Indonesian Breast Cancer Patients for DNA Vaccine Development

pcrOver-expression of proto-oncogene her-2occurs in 20–30% of the total breast cancer cases associated with increased metastatic potential and poor prognosis. It consists of a 620 aa extracellular domain, followed by a 23 aa trans-membrane domain and a 490 aa intracellular domain with tyrosine kinase activity. Treatment using the monoclonal antibody, trastuzumab, was an expensive treatment with an incidence rate of resistance in single use reaches a high percentage of 66-88%. until now, there are continuous efforts for materials or methods improvement for her-2breast cancer treatment. vaccination is an attractive alternative approach to provide protective immunity.

prosiding nabati 2014

prosidingpeternakan2014

isibio

Lock full review www.8betting.co.uk 888 Bookmaker

icon-pelatihan-b

icon-kunjunganilmiah-b

icon-pengujianbiotek-b

icon-pembimbingan-b

Pusat Penelitian Bioteknologi LIPI